Publications by authors named "A Bohacs"
Background: Donor-specific antibodies (DSAs) are common following lung transplantation (LuTx), yet their role in graft damage is inconclusive. Mean fluorescent intensity (MFI) is the main read-out of DSA diagnostics; however its value is often disregarded when analyzing unwanted post-transplant outcomes such as graft loss or chronic lung allograft dysfunction (CLAD). Here we aim to evaluate an MFI stratification method in these outcomes.
View Article and Find Full Text PDFDiagnosing interstitial lung disease (ILD) can be a challenging process. New biomarkers may support diagnostic decisions. Elevated serum progranulin (PGRN) levels have been reported in liver fibrosis and dermatomyositis-associated acute interstitial pneumonia.
View Article and Find Full Text PDFCOVID-19 is often associated with long-lasting pulmonary symptoms. Data are scarce about interstitial lung disease (ILD) in patients following COVID-19 hospitalization with persistent symptoms. We retrospectively reviewed all cases sent to pulmonary post-COVID evaluation due to persistent symptoms between February 2021 and February 2022 (N = 318).
View Article and Find Full Text PDFBackground: Both lung transplant recipients and candidates are characterised by reduced training capacity and low average quality of life (QoL). This review investigates the impact of training on exercise ability and QoL in patients before and after lung transplant.
Methods: Searches were conducted from the beginning to 7 March 2022 using the terms "exercise," "rehabilitation," "lung transplant," "exercise ability," "survival," "quality of life" and "telerehabilitation" in six databases, including Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, CINAHL, Nursing and Allied Health, and Scopus.
Article Synopsis
- Lung transplant recipients face serious risks from infections, particularly COVID-19, which can impact lung allograft function and lead to complications.
- A case study of a 53-year-old female patient revealed acute allograft rejection and thyroid complications following a COVID-19 infection, despite initial clinical improvement.
- Treatment involved high-dose steroids, immunosuppressive therapy adjustments, and plasmapheresis; however, her lung function did not fully return to pre-COVID levels, highlighting the potential long-term effects of COVID-19 on graft health.